Infosys Limited (BOM:500209)
India · Delayed Price · Currency is INR 1,123.15
-38.80 (-3.34%)
At close: Oct 28, 2026
Infosys Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 20,367 | 20,158 | 19,277 | 18,562 | 18,212 | 16,311 |
Revenue Growth | 3.45% | 4.57% | 3.85% | 1.92% | 11.65% | 20.28% |
Gross Profit Gross Profit Growth | 6,060 | 5,950 | 5,749 | 5,466 | 5,387 | 5,315 |
Operating Income Operating Income Growth | 4,151 | 4,089 | 4,089 | 3,835 | 3,826 | 3,755 |
Net Income Net Income Growth | 3,303 | 3,313 | 3,158 | 3,167 | 2,981 | 2,963 |
Earnings Per Share EPS Growth | 0.80 | 0.80 | 0.76 | 0.76 | 0.71 | 0.70 |
EPS Growth | 1.52% | 5.26% | 0% | 7.04% | 1.43% | 14.75% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Financial Services Revenue from Operations Financial Services Revenue from Operations Growth | 530,300 | 499,080 | 451,750 | 421,580 | 437,630 | 389,020 |
Manufacturing Revenue from Operations Manufacturing Revenue from Operations Growth | 305,090 | 290,780 | 252,070 | 222,980 | 190,350 | 133,360 |
Energy, Utilities, Resources and Services Revenue from Operations Energy, Utilities, Resources and Services Revenue from Operations Growth | 255,570 | 238,180 | 217,100 | 200,350 | 185,390 | 144,840 |
Retail Revenue from Operations Retail Revenue from Operations Growth | 236,230 | 230,770 | 220,590 | 225,040 | 212,040 | 177,340 |
Communication Revenue from Operations Communication Revenue from Operations Growth | 232,110 | 217,650 | 191,080 | 179,910 | 180,860 | 151,820 |
Life Sciences Revenue from Operations Life Sciences Revenue from Operations Growth | 146,470 | 122,670 | 118,310 | 115,150 | 100,850 | 85,170 |
Hi-Tech Revenue from Operations Hi-Tech Revenue from Operations Growth | 139,710 | 139,280 | 130,900 | 124,110 | 118,670 | 100,360 |
All Other Revenue from Operations All Other Revenue from Operations Growth | 47,880 | 48,090 | 48,100 | 47,580 | 41,880 | 34,500 |
Other Other Growth | - | 97,962 | 17,673 | 10,722 | 29,006 | 21,749 |
Revenue (Total) Revenue (Total) Growth | - | 1,884,462 | 1,647,573 | 1,547,422 | 1,496,676 | 1,238,159 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 3,977 | 3,706 | 4,321 | 3,321 | 2,322 | 3,185 |
Total Debt Total Debt Growth | 890 | 967 | 962 | 1,002 | 1,010 | 722 |
Net Cash (Debt) Net Cash Growth | 3,087 | 2,739 | 3,359 | 2,319 | 1,312 | 2,463 |
Net Cash Growth | -23.19% | -18.46% | 44.85% | 76.75% | -46.73% | -17.13% |
Net Cash Per Share Net Cash Per Share Growth | 0.76 | 0.66 | 0.81 | 0.56 | 0.31 | 0.58 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3,949 | 4,039 | 4,351 | 3,148 | 2,853 | 3,345 |
Capital Expenditures CapEx Growth | -318 | -306 | -263 | -266 | -319 | -290 |
Free Cash Flow Free Cash Flow Growth | 3,631 | 3,733 | 4,088 | 2,882 | 2,534 | 3,055 |
Free Cash Flow Growth | -12.29% | -8.68% | 41.85% | 13.73% | -17.05% | 2.76% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 29.75% | 29.52% | 29.82% | 29.45% | 29.58% | 32.58% |
Operating Margin | 20.38% | 20.29% | 21.21% | 20.66% | 21.01% | 23.02% |
Pretax Margin | 22.20% | 22.35% | 23.07% | 23.41% | 22.65% | 24.74% |
Profit Margin | 16.22% | 16.43% | 16.38% | 17.06% | 16.37% | 18.17% |
FCF Margin | 17.83% | 18.52% | 21.21% | 15.53% | 13.91% | 18.73% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 51.000 | 0.520 | 0.510 | 0.460 | 0.410 | 0.410 |
Dividend Per Share Growth | 13.33% | 1.96% | 10.87% | 12.20% | 0% | 13.89% |
Dividend Yield | 4.54% | 3.90% | 2.77% | 2.56% | 2.38% | 1.63% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.64 | 16.29 | 24.11 | 23.50 | 23.94 | 35.55 |
P/FCF Ratio | 13.07 | 14.46 | 18.63 | 25.83 | 28.17 | 34.48 |
PS Ratio | 2.33 | 2.68 | 3.95 | 4.01 | 3.92 | 6.46 |